ExploreWatchlistsPricing
  1. JP-listed companies
  2. KOWA COMPANY, LTD.
  3. Financials
  4. Marketable securities, non-current

KOWA COMPANY, LTD. (E02819)

Market cap
P/E ratio
Kowa develops and sells prescription and over-the-counter medicines including popular nutritional drinks and cold remedies, while also operating trading, optical equipment, and hospitality businesses across 117 global subsidiaries.
SummaryFinancialsDividendsHistoryWorkforce
Period EndMarketable securities, non-current (Million JPY)YoY (%)
Mar 31, 202333,789-25.35%
Mar 31, 202245,265+2.50%
Mar 31, 202144,159+51.62%
Mar 31, 202029,124+18.54%
Mar 31, 201924,568-6.97%
Mar 31, 201826,409+8.81%
Mar 31, 201724,271+12.13%
Mar 31, 201621,646-8.51%
Mar 31, 201523,660+15.93%
Mar 31, 201420,408-12.77%
Mar 31, 201323,395

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat